Discontinued — last reported Q3 '20

Finite-Lived Intangible Assets - Expected Amortization Expense (Year Four)

Non-Current Assets

Amgen Finite-Lived Intangible Assets - Expected Amortization Expense (Year Four) decreased by 3.4% to $2.80B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.4%, from $2.90B to $2.80B.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryProfitability
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ3 2020

How to read this metric

A decrease suggests lower future non-cash charges, potentially boosting reported net income, while an increase reflects significant recent asset acquisitions.

Detailed definition

This represents the projected non-cash expense associated with the amortization of finite-lived intangible assets, such...

Peer comparison

Standard disclosure for pharmaceutical companies with significant M&A activity and R&D pipelines.

Metric ID: finite_lived_intangible_assets_amortization_year_4

Historical Data

10 periods
 Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$1.80B$2.10B$2.10B$2.10B$2.90B$2.90B$2.90B$2.80B$2.90B$2.80B
QoQ Change+16.7%+0.0%+0.0%+38.1%+0.0%+0.0%-3.4%+3.6%-3.4%
YoY Change+16.7%+38.1%+38.1%+38.1%-3.4%+0.0%-3.4%
Range$1.80B$2.90B
CAGR+21.7%
Avg YoY Growth+17.7%
Median YoY Growth+16.7%

Frequently Asked Questions

What is Amgen's finite-lived intangible assets - expected amortization expense (year four)?
Amgen (AMGN) reported finite-lived intangible assets - expected amortization expense (year four) of $2.80B in Q3 2025.
How has Amgen's finite-lived intangible assets - expected amortization expense (year four) changed year-over-year?
Amgen's finite-lived intangible assets - expected amortization expense (year four) decreased by 3.4% year-over-year, from $2.90B to $2.80B.
What does finite-lived intangible assets - expected amortization expense (year four) mean?
The expected accounting expense for intangible assets in the fourth year from now.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.